Vitalhub

VHI.TO

Medical - Healthcare Information Services · Healthcare

Exchange

Toronto Stock Exchange

Winston Score

Winston is curious

A decent business — some strong pillars, some weaker.

Data as of Aug 23, 2026 · filings through Jun 30, 2026

How the score breaks down

Quality

Good

Growth

Good

Cash Flow

Exceptional

Stability

Good

Valuation

Good

Track this stock — start free trial

Winston Score History

The full picture

Vitalhub Corp. is a Canadian software company that builds digital tools for hospitals, mental health facilities, and other healthcare providers. Its products help clinical staff track patients, manage workflows, and coordinate care — things like electronic whiteboards, patient flow systems, and case management software. The company focuses on public health systems, particularly in Canada, the United Kingdom, and Australia.

Vitalhub makes money by selling software licenses and recurring subscription contracts to healthcare organizations, which helps explain its high gross margin near 75%. It is a small-cap company with a market value around $400 million, and it has grown partly through acquisitions of niche healthcare IT products. Its competitive position comes from deep integration into government-funded health systems, which tend to be sticky customers that are slow to switch vendors. The main risk is that growth depends heavily on continued acquisitions and winning contracts from budget-constrained public health systems, which can be slow to spend.

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+33.0% YoY

YoY Growth Rate

Strong revenue growth

EPS Growth

-5.4% YoY

YoY Growth Rate

Earnings declining

Insider Activity

11.6%ownership

→ Flat

Insider ownership roughly steady over the past year

Cash Position

Cash flow positive

C$137M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Strong grower

Vitalhub is growing revenue at 33% year-over-year. The Winston Score penalises unprofitable companies, but revenue at this pace tells a different story — this is a company still in "build mode."

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

79.3%

Premium pricing power — 79.3% gross margin

Profit after running costs

Operating Margin

13.7%

Healthy — 13.7% operating margin

Return on the money invested

ROCE

5.6%

Weak — 5.6% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

+53.8%

Fast-growing sales (+53.8% YoY)

Profit growth

EPS YoY

+27.9%

Earnings growing fast (+27.9% YoY)

Earnings growing 25%+ a year. The compounder zone.

How steady the profit is

EPS Consistency

3/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

285%

Turns 285% of profit into real cash

Spare cash per sale

FCF Margin

16.3%

Converts sales into free cash efficiently (16.3%)

FCF margin between 10% and 20%. Every $100 in sales becomes $10 to $20 in real cash.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

N/A

Data not available

Covers its interest

Interest Cover

122.36x

Comfortably covers interest (122.4x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

66.7x

no trend

Expensive — P/E 66.7

P/E over 35. The market is pricing in heavy, sustained growth.

Cheaper or dearer next year

P/E vs Forward

+41.9

GROWING

Earnings expected to grow meaningfully — cheaper on forward P/E (66.7 → 24.8)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial